Certified French language Translation of PUBLIC JUDGMENT AND REASONS rendered on 26-FEB-2015 by The Honourable Mr. Justice Barnes filed on 21-JAN-2016 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of PUBLIC JUDGMENT AND REASONS entered in J. & O. Book, volume 1290 page(s) 151 - 151 and copy placed on file.

Copy of Discontinuance dated 13-APR-2015 placed on file on 16-APR-2015 Original filed on Court File No. A-262-14

Acknowledgment of Receipt received from all parties with respect to the Public Judgment and Reasons of the Court doc. 91 placed on file on 27-FEB-2015

Reasons for Judgment and Judgment (PUBLIC) dated 26-FEB-2015 rendered by The Honourable Mr. Justice Barnes Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed Filed on 26-FEB-2015 Transmittal Letters placed on file. Final Decision Certificate of Judgment entered in J. & O. Book, volume 1259 page(s) 213 - 213

Acknowledgment of Receipt received from all parties with respect to Order of the Court doc. 90 placed on file on 16-FEB-2015

Order dated 12-FEB-2015 rendered by The Honourable Mr. Justice Barnes Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 77 Result: THIS COURT ORDERS that Confidential Judgment and Reasons dated December 10, 2014 will be redacted in a form to be circulated to the parties alond with this Order. THIS COURT FURTHER ORDERS that the redacted Public Judgment and Reasons herein will be issued by the Court after ten days from the date of this Order unless, in the meantime, a stay of this Order has been obtained. THIS COURT FURTHER ORDERS that there will be no costs of this motion. Filed on 12-FEB-2015 entered in J. & O. Book, volume 1258 page(s) 95 - 98 Interlocutory Decision

Copy of Reasons for Order and Order dated 04-FEB-2015 rendered by The Honourable Mr. Justice Stratas The Honourable Mr. Justice Ryer The Honourable Mr. Justice Boivin placed on file. Original filed on Court File No. A-561-14

Communication to the Court from the Registry dated 05-FEB-2015 re: Reply Of the Applicant and Respondent Patentee (Millennium Pharmaceuticals, Inc.) sent directly to the Court.

Covering letter from Applicant and Respondent Patentee Millenium dated 04-FEB-2015 concerning Doc. Nos. 87 88 placed on file on 04-FEB-2015

Solicitor's certificate of service on behalf of Beverley Moore confirming service of Documents 87 and 88 upon all parties by personal service and by electronic service on 04-FEB-2015 filed on 04-FEB-2015

Confidential Motion Record Volume 2: For Public Version see Doc. No.87 filed on behalf of Applicant and Respondent Millennium filed on 04-FEB-2015

Motion Record containing the following original document(s): 86 Number of copies received: 3 on behalf of Applicant and Respondent, Millennium filed on 04-FEB-2015

Reply Representations contained within a Motion Record on behalf of Applicant and Respondent Millennium in response to the opposing submissions doc. No. 84 to the Motion in writing Filed on 04-FEB-2015

Communication to the Court from the Registry dated 04-FEB-2015 re: Responding Motion Record of Teva Canada Limited sent directly to the Court.

Covering letter from Respondent, Teva Canada Limited dated 30-JAN-2015 concerning Responding motion record and Book of Authorities placed on file on 30-JAN-2015

Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of doc. #83 and Book of Authorities upon all parties by email on consent with hard copy to follow on 30-JAN-2015 filed on 30-JAN-2015

Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Teva Canada Limited received on 30-JAN-2015

Motion Record in response to Motion Doc. No. 77 containing the following original document(s): 83 Number of copies received: 3 on behalf of Respondent, Teva Canada Limited filed on 30-JAN-2015

Written Representations contained within a Motion Record on behalf of Respondent, Teva Canada Limited concerning Motion in writing Doc. No. 77 filed on 30-JAN-2015

Communication to the Court from the Registry dated 27-JAN-2015 re: Motion Record of the Applicant and the Respondent Patentee sent to the Case Management Judge (Barnes, J.). Document #81

Letter from Applicant, Janssen Inc. and the Respondent Patentee. dated 27-JAN-2015 "We write further to the letter from Teva Canada Limited dated January 23, 2015, and the case management conference on January 14, 2015. Please treat Janssen and Millenium's motion, which was served and filed on January 23, 2015, as a motion in writing pursuant to Rule 369 of the Federal Courts Rules." received on 27-JAN-2015

Letter from Applicant Janssen Inc and Respondent (Patentee) dated 23-JAN-2015 "...This is further to the Oral Direction dated January 14, 2015, in which Janssen and Millennium were directed to file a motion concerning its proposed redactions to the draft decision. Please find enclosed Janssen and Millennium's Motion Record and Book of Authorities received on 23-JAN-2015

Solicitor's certificate of service on behalf of Beverley Moore confirming service of Motion Record and Book of Authorities upon Respondent (Teva Canada Limited) by personal service on 23-JAN-2015 confirming service Motion Record and Book of Authorities upon Respondent (Minister of Health) by having a copy delivered electronically on 23-JAN-2015 filed on 23-JAN-2015

Book of Authorities consisting of 1 volume(s) on behalf of Applicant Janssen Inc & Respondent Patentee received on 23-JAN-2015

PUBLIC VERSION OF MOTION RECORD NO.81 Containing the following documents 77, 78, 79, 80. 3 copies received on 23-JAN-2015

Motion Record containing the following original document(s): 77 78 80 Number of copies received: 3 on behalf of Applicant Janssen Inc & Respondent Patentee (MOTION RECORD IS CONFIDENTIAL) filed on 23-JAN-2015

Written Representations (CONFIDENTIAL) contained within a Motion Record on behalf of Applicant Janssen Inc & Respondent Patentee concerning Motion in writing Doc. No. 77 filed on 23-JAN-2015

Affidavit of Lisa Mackie sworn on 23-JAN-2015 contained within a Motion Record on behalf of Applicant Janssen Inc & Respondent Patentee in support of Motion Doc. No. 77 filed on 23-JAN-2015

Affidavit of Karoline Shair (CONFIDENTIAL) sworn on 23-JAN-2015 contained within a Motion Record on behalf of Applicant Janssen Inc & Respondent Patentee in support of Motion Doc. No. 77 filed on 23-JAN-2015

CONFIDENTIAL NOTICE OF MOTION contained within a Motion Record on behalf of Applicant Janssen Inc & Respondent Patentee in writing to be placed before the Court in Ottawa for an Order (Motion for a Protective and Confidentiality Order) filed on 23-JAN-2015

Letter from Respondent dated 23-JAN-2015 in relation to the Applicant's motion for a protective and confidentiality order with respect to the Court's reasons for judgment...the Applicant's motion...was to be a motion in writing. Accordingly, we will serve and file the Respondent Teva's responding motion record with the understanding that the motion will be determined based on the written record... (scanned to presiding Judge) received on 26-JAN-2015

Ottawa 14-JAN-2015 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Case Management Conference Result of Hearing: Applicant may file material re: redactions within 10 days; held in Court Senior Usher: P. Gendron Duration per day: 14-JAN-2015 from 10:01 to 10:14 Courtroom : Courtroom No. 701, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Anil Kamal Total Duration: 14min Appearances: Ms. Chantal Saunders (613) 369-4783 representing Applicant and Respondent Patentee, Millennium Pharmaceuticals, Ltd., Mr. David Aitken, Mr. Bryan Norrie, and Mr. Jeffrey Warnock (613) 903-5107 representing Respondent, Teva Canada Limited, Mr. Kiernan Murphy (613) 563-9869 representing Respondent Patentee, United States of America; no one appearing on behalf of Respondent, Minister of Health; Minutes of Hearing entered in Vol. 920 page(s) 222 - 224 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 09-JAN-2015 directing that "A Case Management Conference will take place on Wednesday, January 14, 2015 10:00 a.m. for an hour in duration. Parties are to attend the Ottawa Registry"; placed on file on 09-JAN-2015 Confirmed in writing to the party(ies)

Letter from Respondent Teva dated 02-JAN-2015 inquiring whether the Court still intends to arrange a conference call, or if the written cost submissions should simply be filed in accorandance with the Federal Courts Rules... (scanned to presiding Judge) received on 02-JAN-2015

Copy of Notice of Appeal (Appeal Court File No. A-561-14 ) appealing the decison of Barnes, J. dated 10-DEC-2014 filed in the Court of Appeal on 22-DEC-2014 on behalf of Applicant placed on file on 30-DEC-2014

Communication to the Court from the Registry dated 23-DEC-2014 re: File sent to Court re: parties submissions in redaction in Confidential Reasons

Letter from Respondent - Teva Canada Limited dated 19-DEC-2014 re: response to the Applicant's letter dated December 19, 2014 regarding portions of the Confidential Reasons suggested by the Applicant which should be redacted. received on 22-DEC-2014

****** CANCELLED ****** Communication to the Court from the Registry dated 23-DEC-2014 re: Letter received from the Respondent further to the Court's Direction of December 10, 2014 sent to Court re: late receipt

Letter from Applicant dated 19-DEC-2014 in response to the Court's Direction of December 10, 2014 providing submissions as to which portions of the Judgment and Reasons should be maintained as confidential. received on 19-DEC-2014

Acknowledgment of Receipt received from all parties, via e-mail, with respect to Doc. No. 76 and Direction of the Court rendered 10-DEC-2014; placed on file on 10-DEC-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 10-DEC-2014 directing that the attached CONFIDENTIAL Judgment and Reasons is filed forthwith under seal. Janssen and the related parties shall have until Friday, December 19, 2014 at noon to make submissions concerning proposed redactions, if any, to the attached CONFIDENTIAL Judgment and Reasons before it is released publicly. Teva Canada Limited will have two days to respond in writing. Neither submission is to exceed 3 pages; placed on file on 10-DEC-2014 Confirmed in writing to the party(ies)

Reasons and Judgment (CONFIDENTIAL) dated 10-DEC-2014 rendered by The Honourable Mr. Justice Barnes Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: CONFIDENTIAL Filed on 10-DEC-2014 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1251 page(s) 407 - 407

Letter from all parties dated 27-NOV-2014 further to the Direction of the Court rendered 20-NOV-2014 attaching a Draft Order; received on 27-NOV-2014

Acknowledgment of Receipt received from all parties, via e-mail, with respect to Doc. No. 75 placed on file on 29-NOV-2014

Order dated 28-NOV-2014 rendered by The Honourable Mr. Justice Barnes Matter considered without personal appearance The Court's decision is with regard to Letter from all parties 27-nov-2014 dated 10-NOV-2014 Result: "The 24-motnh period in the above-noted proceeding, which is set to expire on December 7, 2014, shall be extended by two (2) weeks, namely until December 21, 2014; Filed on 28-NOV-2014 copies sent to parties entered in J. & O. Book, volume 1250 page(s) 210 - 211 Interlocutory Decision

Letter from Applicant dated 19-NOV-2014 (CONFIDENTIAL as per Court's instructions); received on 19-NOV-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 20-NOV-2014 directing that (terms of Direction CONFIDENTIAL as per Court's instructions); placed on file on 20-NOV-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-NOV-2014 re: letter (submissions) on behalf of respondent Teva, sent to presiding Judge for consideration.

Letter from Respondent dated 10-NOV-2014 in response to the Direction of Justice Barnes dated November 7, 2014 granting leave to provide submissions regarding the decision in Pfizer Canada Inc. v. Apotex Inc., 2014 FCA 250...(see content of letter for submissions) received on 10-NOV-2014

Acknowledgment of Receipt received from all parties, via e-mail, with respect to Directions of the Court rendered 07-NOV-2014; placed on file on 07-NOV-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 07-NOV-2014 directing that "Having received correspondence from both counsel dated November 6, 2014, the Court directs that counsel for Teva Canada Limited shall have leave to have leave to respond by letter not exceeding two pages"; placed on file on 07-NOV-2014 Confirmed in writing to the party(ies)

Letter from Respondent, Teva Canada Ltd., dated 06-NOV-2014 in response to the letter from the Applicant dated 6-NOV-2014, providing brief written submissions as to the FCA decision provided to the Court by the Applicant in attachment to their letter dated 6-NOV-2014. - scanned to the presiding Judge - received on 06-NOV-2014

Letter from Applicant dated 06-NOV-2014 requesting that it be brought to the attention of Justice Barnes. "We wish to refer the Court to a recent decision of the Federal Court of Appeal that, in counsel's view, should be considered by this Court prior to the determination of the above-noted matter...(Federal Court of Appeal decision in A-194-14 & A-94-14 dated October 30, 2014 attached) ***scanned to Barnes, J. received on 06-NOV-2014

Invoice from Court Reporter received on 30-SEP-2014

Transcript of hearing held at Ottawa on 08-SEP-2014 received on 29-SEP-2014 Sent directly to presiding Judge 443 pages (including covering pages).

Request received from the Court for Transcript of Hearing of 08-SEP-2014 to 12-SEP-2014; sent to ASAP Reporting Services Inc. via e-mail; placed on file on 16-SEP-2014

Letter sent by Registry on 28-AUG-2014 to ASAP Reporting Services Inc. requesting the services of a court report for the hearing slated for 08-SEP-2014 to 12-SEP-2014; Copy placed on file.

Ottawa 08-SEP-2014 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Brian Cooper Duration per day: 08-SEP-2014 from 09:40 to 16:29 Courtroom : Competition Tribunal, Room 610 - Ottawa Court Registrar: Anil Kamal 09-SEP-2014 from 09:34 to 16:53 Courtroom : Competition Tribunal, Room 610 - Ottawa Court Registrar: Anil Kamal 10-SEP-2014 from 09:37 to 13:32 Courtroom : Competition Tribunal, Room 610 - Ottawa Court Registrar: Anil Kamal Total Duration: 2d3h55min Appearances: Mr. Jamie Mills, Ms. Chantal Saunders, Ms. Beverly Moore, & Mr. Ryan Steeves (613) 369-2782 representing Applicant Mr. David Aitken, Mr, Bryan Norrie, & Mr. Jeffrey Warnock (613) 903-5099 representing Respondent, Teva Canada Limited, Court Reporter: Ms. Nancy Grindley (613) 564-2727 08-SEP-2014 Ms. Suzanne Hubbard (613) 564-2727 09-SEP-2014 Ms. Suzanne Hubbard (613) 564-2727 10-SEP-2014 Transcript requested Comments: DARS Z005108 used; Minutes of Hearing entered in Vol. 913 page(s) 1 - 31 Abstract of Hearing placed on file

Supplemental Book of Authorities: Utility consisting of 1 volume(s) on behalf of Respondent, Teva Canada Limited, received on 10-SEP-2014 Sent directly to Presiding Judge

Patent '936 consisting of 1 volume(s) on behalf of Respondent, Teva Canada Limited, received on 09-SEP-2014 Sent directly to Presiding Judge

Compendium consisting of 2 volume(s) on behalf of Respondent, Teva Canada Limited, received on 09-SEP-2014 Sent directly to Presiding Judge

Daybook: Utility consisting of 1 volume(s) on behalf of Applicant received on 09-SEP-2014 Sent directly to Presiding Judge

Daybook: The '936 Patent is not a Selection consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2014 Sent directly to Presiding Judge

Daybook: Inventiveness Vol. 2 consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2014 Sent directly to Presiding Judge

Daybook (Inventiveness) Vol. 1 consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2014 Sent directly to Presiding Judge

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2014 Sent directly to Presiding Judge

CONFIDENTIAL Daybook (Science Primer and Bortezomib Theory) consisting of 1 volume(s) on behalf of Applicant received on 08-SEP-2014 Sent directly to Presiding Judge

Letter from Applicant dated 05-SEP-2014 advising that the parties have discussed the hearing of both matters (T-2194-12 and T-2195-12) and provide the Court with a proposed schedule for the hearing and other information requested by the Court. - scanned to the Hearings Judge - received on 05-SEP-2014

Covering letter from Teva Canada Limited dated 22-AUG-2014 concerning 73, 74, and enclosing copy of letter to opposing counsel placed on file on 22-AUG-2014

Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of document 73 upon Applicant and Respondent Patentee by personal service on 22-AUG-2014 confirming service document 73 upon Respondent, Minister of Health by e-mail on 22-AUG-2014 filed on 22-AUG-2014

(Public version) of Respondent Teva Canada Limited (Redacted) Number of copies received/prepared: 3 on behalf of Respondent filed on 22-AUG-2014

Letter from Janssen Inc. and Millennium Pharmaceuticals Inc. dated 18-AUG-2014 Further to the teleconference on Aug. 5/14 Janssen and Millennium will not be bringing a motion for recusal (scanned to the Court) received on 18-AUG-2014

Ottawa 05-AUG-2014 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Meeting to discuss the Applicant's July 10, 2014 letter, and the hearing scheduled for September 8, 2014. (This matter and T-2195-12) Result of Hearing: The Court advises the Applicant that a request for recusal would need to be made by way of a motion. The Applicant is asked to advise as soon as possible if this is their intent. Parties are asked to work on a document outlining the points on which the parties agree, for use by the Court at the hearing. held by way of Conference Call Duration per day: 05-AUG-2014 from 10:00 to 10:12 Courtroom : Ottawa Registry Office Court Registrar: Danielle Lanteigne Total Duration: 12min Appearances: Mr. Jamie Mills, Ms. Chantal Saunders 613-369-4782 representing Applicant Mr. Marcus Klee, Mr. Bryan Norrie 613-903-5100 representing Respondent Comments: Mr. Kiernan Murphy and Mr. Christopher Van Barr were also present; their client (USA, by Secretary, Dept of Health and Human Services) is a respondent patentee only in related file T-2195-12. Minutes of Hearing entered in Vol. 910 page(s) 471 - 473 Abstract of Hearing placed on file

Memorandum to file from D. Lanteigne, Ottawa dated 05-AUG-2014 the Court has directed that the Digital Audio Recording System (DARS) NOT be used for this morning's meeting by teleconference. placed on file.

Acknowledgment of Receipt received from all parties (by e-mail) with respect to the oral Diretion of the Court dated 28-JUL-2014 placed on file on 29-JUL-2014

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 28-JUL-2014 directing that "The document is accepted for filing and is to replace Tab 6 of the Application Record filed June 4, 2014." placed on file on 28-JUL-2014 Confirmed in writing to the party(ies)

Affidavit of service of Cindy Sue Potter sworn on 23-JUL-2014 on behalf of Applicant confirming service of the replacement copy of Tab 6 of Volume 2 of the Applicant/Respondent Patentee's Application Record upon Respondent, Teva Canada Ltd., by personal service on 21-JUL-2014 confirming service the replacement copy of Tab 6 of Volume 2 of the Applicant/Respondent Patentee's Application Record upon Respondent, Minister of Health, by e-mail on 21-JUL-2014 with Exhibits A filed on 23-JUL-2014

Consent on behalf of all parties to the Applicant and Respondent Patentee filing a replacement copy of Tab 6 to be inserted in Volume 2 of the Applicant and Respondent Patentee's Application Record previously filed on June 4, 2014 filed on 23-JUL-2014

Communication to the Court from the Registry dated 24-JUL-2014 re: Letter from Applicant dated 23-JUL-2014 and request to replace Tab 6 of Applicant's Record on consent

Letter from Applicant dated 23-JUL-2014 advising that it has recently come to thier attention that there was an error made at Vol. 2, Tab 6 of their Application Record served and filed on June 4, 2014. The parties have discussed this oversight and, on consent, a replacement copy of Tab 6 was served on each of the parties this week. Enclosed is a signed consent of the parties together with three copies of Tab 6 to be inserted in Vol. 2 of the Application Record with leave of the Court. An Affidavit of Service is also included. received on 23-JUL-2014

Memorandum to file from Victoria Bell - Registry Officer Ottawa dated 24-JUL-2014 I spoke with counsel for Teva (J. Warnock) this afternoon with regard to his letter of July 21, 2014 and the letter received in response on July 23, 2014. Counsel indicated that the parties are discussing the matter and that if intervention by the Court is required that they will write and request such. placed on file.

Letter from Applicant dated 23-JUL-2014 futher to letter from the Respondent dated July 21, 2014 seeking specific instructions from the applicant concerning portions of their record which are confidential. Applicant unsure of what further clarification is required Teva. received on 24-JUL-2014

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 23-JUL-2014 directing that a teleconference will be held on 5-AUG-2014 at 10 a.m. Ottawa time. Parties are to remain in their respective offices. placed on file on 23-JUL-2014

Letter from Respondent TEVA CANADA LIMITED dated 21-JUL-2014 re: confidential copies of the Application Record and Book of Authorities for filing. 'Since counsel for the Applicant has marked their record confidential, Teva has only included a confidential version. We would request further specific instructions from the Applicant as to which portions of their Application Record are confidential before we can file a public version.' received on 21-JUL-2014

Copy of letter from TEVA CANADA LIMITED to other parties re: Application Record and Book of Authorities placed on file on 21-JUL-2014

Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of Confidential Application Respondent's Record and Book of Authorities upon all parties by personal service(Applicant and Resp. Patentee)email (Resp.Min. of Health) on 21-JUL-2014 filed on 21-JUL-2014

Book of Authorities consisting of 2 volume(s) on behalf of Respondent TEVA CANADA LIMITED received on 21-JUL-2014

Sealed envelope pursuant to Order of the Court of 29-AUG-2013 on behalf of Respondent TEVA CANADA LIMITED purporting to contain Application Record Filed on 21-JUL-2014

Copy of Notice of Appeal (Appeal Court File No. A-262-14 ) appealing the Order dated May 23, 2014 of the Honourable Justice de Montigny filed in the Court of Appeal on 26-MAY-2014 on behalf of Respondent, Teva Canada Ltd. placed on file on 11-JUL-2014

Covering letter from Borden Ladner Gervais LLP, counsel for the Applicant and Respondent Patentee dated 04-JUN-2014 concerning Doc. Nos. 67 68 placed on file on 04-JUN-2014

Solicitor's certificate of service on behalf of Beverley Moore confirming service of the Application Record & Appendix A & B - Book of Authorities of Applicant, Janssen Inc. & Respondent Patentee, Millenium Pharmaceuticals, Inc. upon Respondent, Minister of Health by personal service on 04-JUN-2014 confirming service the Application Record & Appendix A & B - Book of Authorities of Applicant, Janssen Inc. & Respondent Patentee, Millenium Pharmaceuticals, Inc. upon Respondent, Teva Canada Limited by process server on 04-JUN-2014 filed on 04-JUN-2014

Applicant's and Respondent Patentee's Record (25 vols and Appendix A & B) Number of copies received/prepared: 3 on behalf of Applicant and Respondent Patentee filed on 04-JUN-2014 Document placed in Annexes F G H I J K L M N O P Q R S T U V VE VF

Memorandum to file from Ottawa Registry dated 23-MAY-2014 A copy of the Reasons for Order and Order of Mr. Justice de Montigny was sent to the attention of Madam Prothonotary Mireille Tabib. placed on file.

Acknowledgment of Receipt received from all parties with respect to Reasons for Order and Order (Doc. No. 66). placed on file on 23-MAY-2014

Reasons for Order and Order dated 23-MAY-2014 rendered by The Honourable Mr. Justice de Montigny Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 58 Result: Dismissed, with costs. Filed on 23-MAY-2014 Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1231 page(s) 163 - 163

Letter from Respondent, Teva Canada Limited, dated 22-MAY-2014 further to the Court's Direction of 15-MAY-2014 advising that they have no redactions for the Draft Order and Reasons; received on 22-MAY-2014

Letter from Applicant dated 22-MAY-2014 further to the Court's Direction of 15-MAY-2014 advising that they have no redactions for the Draft Order and Reasons; received on 22-MAY-2014

Confirmation of successful transmission by fax on behalf of Applicant and Respondent with regard to Direction dated May 15, 2014. placed on file on 15-MAY-2014

Oral directions received from the Court: The Honourable Mr. Justice de Montigny dated 15-MAY-2014 directing that This Court directs that although care has been taken to avoid specific reference in the Order and Reasons to matters that the parties may consider confidential, the parties have until May 22, 2014 at 4:30 p.m. to inform the Court if any portions thereof should be deleted or modified. placed on file on 15-MAY-2014 Confirmed in writing to the party(ies)

Notice of Change of Address on behalf of Aitken Klee LLP filed on 29-APR-2014

Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Order of the Court dated 10-FEB-2014 placed on file on 10-FEB-2014

Order dated 10-FEB-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 06-FEB-2014 Result: "1. Cross-examinations on affidavits shall be completed by April 17, 2014. 2. The Applicant and Respondent Licensee's application record shall be served and filed by June 4, 2014. 3. The Respondent's application record shall be served and filed by July 21, 2014." Filed on 10-FEB-2014 copies sent to parties entered in J. & O. Book, volume 1219 page(s) 316 - 317 Interlocutory Decision

Communication to the Court from the Registry dated 06-FEB-2014 re: letter from the Applicant dated 6-Feb-2014

Letter from Applicant dated 06-FEB-2014 further to the Order of Madam Prothonotary Tabib dated December 19, 2013 requesting amendments to the schedule on consent. received on 06-FEB-2014

Ottawa 15-JAN-2014 BEFORE The Honourable Mr. Justice de Montigny Language: E Before the Court: Motion Doc. No. 58 on behalf of Respondent, Teva Canada Limited, Result of Hearing: Matter reserved held in Court Senior Usher: Shawn Young Duration per day: 15-JAN-2014 from 11:06 to 12:35 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Anil Kamal Total Duration: 1h29min Appearances: Mr. Jamie Mills & Ms. Beverley Moore (613) 369-4782 representing Applicant Mr. Bryan Norrie & Mr. Jonathan Giraldi (613) 695-5858 representing Respondent, Teva Canada Limited, Comments: DARS was used for this hearing(Z005109); Minutes of Hearing entered in Vol. 895 page(s) 297 - 300 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 13-JAN-2014 re: Doc. No. 58

Covering letter from Counsel for the Applicant and the Respondent Patentee dated 13-JAN-2014 concerning Doc. Nos. 62 63 placed on file on 13-JAN-2014

Solicitor's certificate of service on behalf of Ryan Steeves confirming service of Document #62 upon Respondents by personal service on 13-JAN-2014 filed on 13-JAN-2014

Book of Authorities consisting of 2 volume(s) on behalf of Applicant and Respondent Patentee, Millennium Pharmaceuticals, Inc. received on 13-JAN-2014

Sealed envelope pursuant to Order of this Court dated 28-AUG-2913 on behalf of Janssen Inc.(Applicants)&Millennium Pharmaceuticals,Inc.(Respondent Patentee purporting to contain Confidential Responding Motion Record to Teva Canada Limited's appeal of the Order of Prothonotary Tabib's Order of 19-DEC-2013 Filed on 13-JAN-2014

Memorandum to file from Ann Murphy - Registry Officer Ottawa dated 09-JAN-2014 a copy of the (Confidential Notice of Motion) to Appeal the decision of Tabib, P. dated 19-Dec-2013 has been forwarded to the Court pursuant to Directive 15 along with a Memorandum. placed on file.

Covering letter from Respondent, Teva Canada Limited dated 08-JAN-2014 concerning 60, 61, Authorities placed on file on 08-JAN-2014

Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of document 60, upon Applicant Respondent Patentee by personal service on 08-JAN-2014 confirming service document 60 upon Respondent Minister of Health by electronically and overnight courier on 08-JAN-2014 filed on 08-JAN-2014

Book of Authorities consisting of 1 volume(s) on behalf of Respondent Teva Canada Limited. received on 08-JAN-2014

Sealed envelope pursuant to order of this Court dated August 28, 2013 on behalf of Respondent, Teva Canada Limited purporting to contain Motion Record (Docs 58-59) Filed on 08-JAN-2014

Written (Confidential) Representations of Teva Canada Limited contained within a Motion Record on behalf of Teva Canada Limited (Respondent) concerning Motion Doc. No. 58 filed on 08-JAN-2014

Confidential Notice of Motion contained within a Motion Record on behalf of Respondent (Teva Canada Limited) returnable at General Sitting in Ottawa on 15-JAN-2014 to begin at 09:30 duration: 2h language: E for a) an order purusant to Rule 51 of the FCR setting aside the Order of Prothonotary Tabib dated 19-Dec-2013 and dismissing Janssen Inc.'s motion for an order striking paragraphs 74-84, 99, 112, 124 and 152-153 of the Affidavit of Professor William W. Bachovchin sworn October 21, 2013; and b) an Order granting Teva its costs of this motion and the motion below. filed on 08-JAN-2014

Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Orders of the Court dated 19-DEC-2013 placed on file on 20-DEC-2013

Order dated 19-DEC-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 17-DEC-2013 re: requesting extensions of time Result: granted "1. Cross-examinations on affidavits shall be completed by March 21, 2014. 2. The Applicant and Respondent Licensee's application record shall be served and filed by May 21, 2014. 3. The Respondent's application record shall be served and filed by July 21, 2014." Filed on 19-DEC-2013 copies sent to parties entered in J. & O. Book, volume 1215 page(s) 93 - 94 Interlocutory Decision

Order dated 19-DEC-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 40 Result: granted in part Filed on 19-DEC-2013 copies sent to parties entered in J. & O. Book, volume 1215 page(s) 75 - 82 Interlocutory Decision

Communication to the Court from the Registry dated 18-DEC-2013 re: letter from the Respondent received 18-DEC-2013

Letter from Respondent dated 17-DEC-2013 requesting extensions of time to the schedule for the completion of the cross-examinations and serving and filing of the application records on consent of the Applicant. received on 18-DEC-2013

Ottawa 16-DEC-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 40 on behalf of Applicant Result of Hearing: Matter reserved held in Court Senior Usher: Dénis Martin Duration per day: 16-DEC-2013 from 09:33 to 12:08 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Victoria Bell Total Duration: 2h 35mins Appearances: Mr. Jamie Mills / Ms. Beverley Moore 613-369-4782 representing Applicant Mr. David Aitken / Mr. Bryan Norrie 613-695-5858 representing Respondent Comments: Mr. Aitken provided the Court with a copy of its decision dated December 2, 2013 in T-894-13. The Digital Audio Recording System (Z005139) was used to record this hearing Minutes of Hearing entered in Vol. 893 page(s) 382 - 397 Abstract of Hearing placed on file

Covering letter from Applicant dated 12-DEC-2013 concerning Doc. Nos. 54 55 placed on file on 12-DEC-2013

Solicitor's certificate of service on behalf of Ryan Steeves confirming service of Supplemental Motion Record and Book of Authorities upon all parties by personal service on 12-DEC-2013 filed on 12-DEC-2013

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 12-DEC-2013

Sealed envelope pursuant to Order dated August 28, 2013 on behalf of Applicant purporting to contain volume 3 of the Applicant's motion record (to strike evidence) Filed on 12-DEC-2013

Draft Order concerning Motion Doc. No. 29 received on 19-AUG-2013

Letter from Teva Canada Ltd. dated 02-DEC-2013 enclosing a USB stick containing Motion Record doc. 51 in sealed envelope pursuant to protective order of the Court received on 02-DEC-2013

Covering letter from Teva Canada Ltd. dated 02-DEC-2013 concerning Doc. Nos. 52 53 placed on file on 02-DEC-2013

Solicitor's certificate of service on behalf of Bryan Norrie confirming service of doc. 51 and authorities upon all parties by personal service and courier on 02-DEC-2013 filed on 02-DEC-2013

Sealed envelope pursuant to Order of the Court dated August 28, 2013 on behalf of Teva Canada Ltd. purporting to contain Confidential Motion Record volumes I and II doc. 51 Filed on 02-DEC-2013

Motion Record in response to Motion Doc. No. 40 containing the following original document(s): 49 50 Number of copies received: 3 on behalf of Teva Canada Ltd. (Confidential) filed on 02-DEC-2013

Written Confidential written representations on behalf of Teva Canada Ltd. concerning Motion Doc. No. 40 filed on 02-DEC-2013

Unsworn affidavit of William Bachovchin (Confidential) contained in the motion record of Teva Canada Ltd. in response to motion doc. 40 received on 02-DEC-2013

Affidavit of Sean Jackson (confidential) sworn on 01-DEC-2013 contained within a Motion Record on behalf of Teva Canada Ltd. in opposition to Motion Doc. No. 40 with Exhibits A to D filed on 02-DEC-2013

Covering letter from Applicant and Respondent Patentee dated 25-NOV-2013 concerning Doc. Nos. 47 48 placed on file on 25-NOV-2013

Solicitor's certificate of service on behalf of the Applicant and Respondent Patentee confirming service of the Applicant and Respondent Patentee's Motion Record (Volume 2) upon Respondent, Teva Canada Ltd., by process server on 25-NOV-2013 confirming service the Applicant and Respondent Patentee's Motion Record (Volume 2) upon the Respondent, AGC, by personal service on 25-NOV-2013 filed on 25-NOV-2013

Book of Authorities consisting of 1 volume(s) on behalf of the Applicant and Respondent Patentee received on 25-NOV-2013

Sealed envelope pursuant to Order of the Court dated August 28, 2013 on behalf of Applicant and Respondent Patentee purporting to contain Volume 2 of the Applicant and Respondent Patentee's Motion Record (to strike evidence) Filed on 25-NOV-2013

Draft Order concerning scheduling received on 18-MAR-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 18-NOV-2013 placed on file on 19-NOV-2013

Ottawa 18-NOV-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: see "Comments" held by way of Conference Call Duration per day: 18-NOV-2013 from 01:15 to 01:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Victoria Bell Total Duration: 10 mins Appearances: Mr. Jamie Mills / Ms. Beverly Moore 613-369-4782 representing Applicant Mr. David Aitken / Mr. Bryan Norrie 613-695-5858 ext 221 representing Respondent Comments: "The Applicant shall serve and file its written representations by November 25, 2013. The Respondent Teva's motion record in response shall be served and filed by December 2, 2013. The Parties may serve and file supplemental written representations arising out of cross-examinations, if any, by December 12, 2013. The Applicant's motion to strike affidavits will be heard at a special sitting in Ottawa beginning at 9:30am on December 16, 2013 for a duration not exceeding 2 hours." Minutes of Hearing entered in Vol. 891 page(s) 67 - 69 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-NOV-2013 directing that "The Applicant shall serve and file its written representations by November 25, 2013. The Respondent Teva's motion record in response shall be served and filed by December 2, 2013. The Parties may serve and file supplemental written representations arising out of cross-examinations, if any, by December 12, 2013. The Applicant's motion to strike affidavits will be heard at a special in Ottawa beginning at 9:30am on December 16, 2013 for a duration not exceeding 2 hours." placed on file on 18-NOV-2013 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 14-NOV-2013 placed on file on 18-NOV-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-NOV-2013 directing that "A case management telephone conference will be held at 1:15pm on November 18, 2013." placed on file on 14-NOV-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 13-NOV-2013 re: applicants' request for case management conference

Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 46). placed on file on 13-NOV-2013

Order (time and place) dated 13-NOV-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 08-SEP-2014 to begin at 09:30 duration: 5d language: E Filed on 13-NOV-2013 cc's sent to parties entered in J. & O. Book, volume 1210 page(s) 41 - 42 Transmittal letters placed on file

Letter from Applicant dated 12-NOV-2013 re: We are counsel for the Applicant. Please bring this letter to the attention of Madam Prothonotary Tabib, Case Managemenent Judge in this proceeding. received on 12-NOV-2013

Solicitor's certificate of service on behalf of Ryan Steeves confirming service of Doc. 44 upon Respondent and Respondent Patentee by personal service on 12-NOV-2013 filed on 12-NOV-2013

Motion Record containing the following original document(s): 40 41 42 43 Number of copies received: 3 on behalf of Applicant (CONFIDENTIAL) filed on 12-NOV-2013

Affidavit of Professor William W. Bachovchin (Confidential) sworn on 21-OCT-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 40 with Exhibits A-B filed on 12-NOV-2013

Affidavit of Cindy Sue Potter (Confidential) sworn on 12-NOV-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 40 with Exhibits A-E filed on 12-NOV-2013

Affidavit of Karoline Shair (Confidential) sworn on 12-NOV-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 40 filed on 12-NOV-2013

Notice of Motion (Confidential) contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order to strike evidence filed on 12-NOV-2013

Covering letter from Respondent (Teva Canada Limited) dated 23-OCT-2013 concerning Doc. No. 39 placed on file on 23-OCT-2013

Solicitor's certificate of service on behalf of Bryan Norrie confirming service of Confidential Affidavit of Professor Sherwin Wilk and Confidential Affidavit of Professor William W. Bachovchin and Affidavit of Sean Jackson upon the Applicant and the Respondent Patentee, Millennium Pharmaceuticals, Inc. by personal service on 22-OCT-2013 confirming service Confidential Affidavit of Professor Sherwin Wilk, Confidential Affidavit of William W. Bachovchin and Affidavit Sean Jackson upon Respondent (Minister of Health) by courier on 22-OCT-2013 filed on 23-OCT-2013

Communication to the Court from the Registry dated 23-OCT-2013 re: File sent to TrialJA to set down hearing date

Letter from Respondent dated 23-OCT-2013 further to the discussion with the Registry regarding dates for the hearing of the application in T-2195-12. The parties have agreed that the week of September 8-12 will be sufficient for the hearing of both T-2194-12 and T-2195-12 if heard together. Counsel for all parties in T-2195-12 have previously confirmed availability for a hearing the week of September 8-12, 2014. received on 23-OCT-2013

Letter from Applicant dated 22-OCT-2013 enclosing Requisition for Hearing. Counsel notes that Requisition sets out dates of availability for the hearing of T-2194-12 and T-2195-12 consecutively. Counsel notes remaining issues for both files. T-2194-12 (936 Patent) 1. Obviousness. 2. Selection 3. Actual Utility. T-2195-12 (146 Patent) 1. Obviousness. 2. S.53 - wilful misleading omission or addition. received on 22-OCT-2013

Solicitor's certificate of service on behalf of Beverley Moore confirming service of docment 37 upon Respondent, Teva Canada Limited by e-mail on 22-OCT-2013 confirming service document 37 upon Respondent, Minister of Health by telecopier on 22-OCT-2013 filed on 22-OCT-2013

Requisition for hearing - Application from Applicant filed on 22-OCT-2013 Tariff Application or appeal - $50.00

Letter from Applicant dated 22-OCT-2013 enclosing cheque to cover filing fee for Requisition for Hearing to be submitted later today. received on 22-OCT-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to Confidentiality Order dated 28-AUG-2013 placed on file on 29-AUG-2013

CONFIDENTIALITY ORDER dated 28-AUG-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 29 Result: granted Filed on 28-AUG-2013 copies sent to parties entered in J. & O. Book, volume 1203 page(s) 207 - 216 Interlocutory Decision

Communication to the Court from the Registry dated 20-AUG-2013 re: Applicant's 369 motion on consent for a protective and confidentiality Order

Covering letter from Applicant dated 19-AUG-2013 concerning Doc. No. 34 placed on file on 19-AUG-2013

Solicitor's certificate of service on behalf of Ryan Steeves confirming service of doc. 34 and authorities upon all parties by courier on 19-AUG-2013 filed on 19-AUG-2013

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 19-AUG-2013

Motion Record containing the following original document(s): 29 30 31 32 33 Number of copies received: 3 on behalf of Applicant filed on 19-AUG-2013

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 29 filed on 19-AUG-2013

Consent on behalf of all parties to motion doc. 29 filed on 19-AUG-2013

Affidavit of Lisa Mackie sworn on 12-AUG-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 29 filed on 19-AUG-2013

Affidavit of James E. Brodie sworn on 17-APR-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 29 filed on 19-AUG-2013

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for a confidentiality order filed on 19-AUG-2013 Draft Order\\Judgment received.

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Order of the Direction of the Court dated 24-JUL-2013 placed on file on 25-JUL-2013

Solicitor's certificate of service on behalf of Beverley Moore with consent to extend the time for filing confirming service of the Applicant and Respondent Patentee's R. 306 evidence upon Respondent by e-mail on 22-JUL-2013 and on 23-JUL-2013 filed on 23-JUL-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-JUL-2013 directing that "extension granted as requested." with regard to the applicant's and respondent patentee's request for an extension of time until July 23, 2013 to serve their affidavit evidence (see letter dated July 22, 2013). placed on file on 24-JUL-2013 Confirmed in writing to the party(ies)

Letter from Applicant dated 23-JUL-2013 enclosing a Solicitor's Certificate of Service regarding service of the Applicant and Respondent Patentee's R. 306 evidence and advising that the Applicant and Respondent Patentee were able to serve part of its evidence on July 22, 2013 with the remaining affidavit evidence being served on July 23, 2013. received on 23-JUL-2013

Communication to the Court from the Registry dated 23-JUL-2013 re: letter and consent received July 22, 2013

Consent on behalf of all parties to an extension of time until July 23, 2013 to serve their R. 306 evidence as set out in the attached Draft Order filed on 22-JUL-2013

Letter from Applicant dated 22-JUL-2013 on consent of the Respondent for an extension of time to serve their evidence by July 23, 2013. received on 22-JUL-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 24 Transmitted by e-mail on 24-APR-2013; receipt acknowledged by all parties on 25-APR-2013 placed on file on 25-APR-2013

Solicitor's certificate of service on behalf of Marcus Klee confirming service of doc. 25 upon all parties by telecopier on 23-APR-2013 filed on 24-APR-2013

Notice of change of solicitor on behalf of Teva Canada Ltd. filed on 24-APR-2013

Order dated 24-APR-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 23-APR-2013 Result: granted "1. Janssen and Millennium's evidence shall be served no later than 22-JUL-2013. 2. Teva's evidence shall be served no later than 22-OCT-2013. 3. Janssen and Millennium shall serve and file a Requisition for Hearing no later than 22-OCT-2013. 4. Janssen and Millennium will advise the parties and the Court whether a Motion pursuant to Rule 312 of the Federal Courts Rules is necessary by 12-NOV-2013 and will provide availability for a case management conference prior to the filing of such Motion. 5. Cross-examinations on affidavits shall be completed by 7-MAR-2014. 6. Janssen and Millennium's Application Record shall be served and filed by 21-APR-2014. 7. Teva's Application Record shall be served and filed by 21-MAY-2014." Filed on 24-APR-2013 copies sent to parties entered in J. & O. Book, volume 1191 page(s) 168 - 169 Interlocutory Decision

Communication to the Court from the Registry dated 24-APR-2013 re: Letter dated 23-APR-2013

Letter from Applicant dated 23-APR-2013 further to the Directions dated 18-APR-2013, setting out a proposed schedule agreed to by the parties... We do not believe that a Case Management Conference is needed in this matter. However, should the Court require one, we are available on the morning of 26-APR-2013 or anytime on 29-APR-2013. received on 23-APR-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-APR-2013 directing that "Counsel for the parties are directed to speak to each other and discuss the practical reasons underlying the timelines each of them has suggested for each step of the proceedings, including whether and how each might be adjusted to take the other parties' concerns or practical constraints into account, and report to the Court, jointly, by 23-APR-2013. Their report shall set out the points on which they agree, and, in respect of points on which they disagree, the rationale for their respective positions. The parties' report will also provide counsel's mutual dates of availability to participate in a case management telephone conference in the week of 29-APR-2013, if necessary. The Court expects Janssen to continue, meanwhile, to diligently work on gathering its evidence and identifying the claims it will be asserting." placed on file on 18-APR-2013 Confirmed in writing to the party(ies)

Letter from Applicant dated 18-APR-2013 further to the letter on behalf of the Respondent Teva Canada Limited dated 17-APR-2013. (scanned to CMJ) received on 18-APR-2013

Letter from Respondent Teva Canada Limited dated 17-APR-2013 "We write to correct the record with respect to certain comments contained in the letter of Ms. Moore dated 15-APR-2013..." (scanned to CMJ) received on 17-APR-2013

Communication to the Court from the Registry dated 17-APR-2013 re: Parties letters regarding failure to reach an agreement as to a proposed schedule (letters dated April 15, 2013)

Letter from the Applicant (Janssen) and the Respondent Patentee (Millennium) dated 15-APR-2013 providing submissions in support of their proposed schedule (schedule is enclosed) received on 15-APR-2013

Letter from Respondent (Teva) dated 15-APR-2013 The parties have unfortunately failed to reach an agreement on a schedule for this proceeding....Teva requests that the schedule be set to correspond with the schedule that was ordered in T-2195-12. (Janssen's proposed schedule is enclosed with a comparison to T-2195-12; a chart providing similarities betwen both files is also enclosed) Teva therefore asks that the schedule in T-2195-12 apply to this application. received on 15-APR-2013

Acknowledgment of Receipt received from all parties by email with respect to doc.23 placed on file on 08-APR-2013

Order dated 08-APR-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 13 Result: dismissed 1. The Applicant's motion is dismissed, with costs in the amount of $1,750.00 payable by the Applicant to the Respondent Teva. 2. The parties shall, by April 15, 2013, consult with each other and file written submissions as to the proposed schedule for the steps to be taken in this application, taking into account that the order of serving evidence will be as provided by the FCR. Filed on 08-APR-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1189 page(s) 60 - 65 Interlocutory Decision

Ottawa 04-APR-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 13 on behalf of Applicant to set a schedule/reversal of evidence Result of Hearing: Matter dismissed Costs are awarded to the Respondent in the amount of $1,750.00. Parties are to provide a joint draft schedule within 10 days of this hearing. If parties cannot agree on a schedule, they are to provide joint submissions (or seperate, if necessary) and mutual dates of availability for a case management conference. held in Court Senior Usher: Héroux, R. Duration per day: 04-APR-2013 from 01:05 to 03:05 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 2h Appearances: Jamie Mills/Ryan Steeves 613-369-4782 representing Applicant Marcus Klee/Martin Brandsna 613-235-7234 representing Respondent Minutes of Hearing entered in Vol. 878 page(s) 88 - 94 Abstract of Hearing placed on file

Affidavit of service of Martin Brandsma sworn on 02-APR-2013 on behalf of Respondent, Teva Canada Limited confirming service of Responding Motion Record and Written Representations upon Minister of Health by email with consent on 02-APR-2013 with Exhibits "A" and "B" filed on 02-APR-2013

Affidavit of service of David Newell sworn on 02-APR-2013 on behalf of Respondent, Teva Canada Limited confirming service of Responding Motion Record, Written Representations and Book of Authorities upon Applicant and Respondent Patentee by process server on 02-APR-2013 filed on 02-APR-2013

Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Teva Canada Limited with proof of service upon Applicant and Respondent Patentee on 02-APR-2013 received on 02-APR-2013

Written Representations on behalf of Respondent, Teva Canada Limited concerning Motion Doc. No. 13 with proof of service upon Applicant and Respondent, Patentee on 02-APR-2013 filed on 02-APR-2013

Motion Record in response to Motion Doc. No. 13 containing the following original document(s): 18 Number of copies received: 3 on behalf of Respondent, Teva Canada Limited filed on 02-APR-2013 with proof of service on Applicant and Respondent Patentee on 02-APR-2013

Affidavit of Martin Brandsma sworn on 02-APR-2013 contained within a Motion Record on behalf of Respondent, Teva Canada Limited in opposition to Motion Doc. No. 13 with Exhibits "A" to "O" filed on 02-APR-2013

Written directions received from the Court: Mireille Tabib, Prothonotary dated 21-MAR-2013 directing that "The Applicant's motion will be heard at a special sitting in Ottawa at 1:00p.m. on April 4, 2013. The Respondent's responding record shall be served and filed by April 2, 2013." placed on file on 21-MAR-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-MAR-2013 re: Respondent's letter dated March 18, 2013

Covering letter from Applicant and Respondent/Patentee Millennium Pharmaceuticals, Inc. dated 21-MAR-2013 concerning Patent No. CA 2,203,936 placed on file on 21-MAR-2013

Certified Copy of Original File relating to patent re: CA 2,203,936 received from Applicant and Respondent/Patentee Millennium Pharmaceuticals, Inc. on 21-MAR-2013 placed on file on this file

Letter from Respondent dated 18-MAR-2013 in response to the Court's March 13 Direction...Teva can serve and file its motion (responding) on April 2. Counsel for the parties are mutually available for a hearing on April 3-5 and 25-26. received on 18-MAR-2013

Covering letter from Applicant dated 15-MAR-2013 concerning Doc. Nos. 13 14 15 16 17 placed on file on 15-MAR-2013

Solicitor's certificate of service on behalf of Beverley Moore confirming service of Motion Record and Book of Authorities upon Respondent (Teva Canada Limited) by Kilrea Bailiff & Process Servers on 15-MAR-2013 confirming service Motion Record and Book of Authorities upon Respondent (Minister of Health) by Lena Camara from BLG's Toronto mail room on 15-MAR-2013 filed on 15-MAR-2013

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 15-MAR-2013

Motion Record containing the following original document(s): 13 14 15 Number of copies received: 3 on behalf of Applicant filed on 15-MAR-2013

Written Representations contained within a Motion Record on behalf of Applicant concerning Motions, Doc. Nos 13 filed on 15-MAR-2013

Affidavit of Cindy Sue Potter sworn on 14-MAR-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 13 with Exhibits A-D filed on 15-MAR-2013

Notice of Motion contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order setting a schedule for the completion of the remaining steps as set out in Schedule "A" and as follows... filed on 15-MAR-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 13-MAR-2013 directing that "The Court is not available until April 2013 to hear the proposed motion. As the parties are in agreement that the Applicant should serve and file its motion record by March 15, 2013, the Court so directs. Teva is to advise of the date by which it can serve and file its responding record, and discuss with the Applicant and Millennium of the need for cross-examinations and the schedule for same, as needed. The parties will then submit to the Court the resulting schedule, their estimate of the time required for hearing the motion and their mutual dates of availabilities for a hearing in April 2013. This will obviate the need for a case management conference in March." placed on file on 13-MAR-2013 Confirmed in writing to the party(ies)

Letter from Respondent, Teva dated 08-MAR-2013 ...Counsel for the corporate parties will be mutually available for a case managment teleconference on March 18-20. (scanned to CMJ) received on 08-MAR-2013

Communication to the Court from the Registry dated 08-MAR-2013 re: Parties seperate submissions on proposed timetable, reversal of evidence and availability for a CMC. (Letters are dated 7-MAR-13)

Letter from Respondent (Teva) dated 07-MAR-2013 further to the direction of the Court dated February 7, 2013...There is no dispute between the parties regarding the following issues: a) no 6(7) motion...b) confidentiality Order will be resolved...c) 6(5) motion is not contemplated...The parties have been unable to reach an agreement on the schedule...Teva proposes the following timetable for the next steps in this application (see letter for details) Counsel for Teva and counsel for the Applicant are available for a teleconference on March 13 and 14. received on 07-MAR-2013

Letter from Applicant dated 07-MAR-2013 The parties are in agreement with respect to all points except the schedule for evidence and the date for Teva's responding motion record in the motion for reverse evidence. Janssen and Millennium do not plan to bring a 6(7) motion. The parties are negotiating a confidentiality order. It is likely we will be able to consent to the terms. We will file a motion seeking issuance of that Order within 2 weeks of consent. Teva has advised it will not bring a 6(5) motion...Janssen and Millennium propose the following schedule, providing for the reversal of evidence:(see letter for details) Teva has not consented to such a schedule. We, thus, propose the following schedule for the filing of motion materials: (see letter) Janssen and Millennium are available for a case conference on March 13-14. received on 07-MAR-2013

Written directions received from the Court: Mireille Tabib, Prothonotary dated 07-FEB-2013 directing that "The parties shall, no later than 7-MAR-2013, either jointly or separately, file written submissions as to the following matters and issues: (a) Whether any Motion pursuant to Section 6(7) of the PM (NOC) Regulations is contemplated, and if so, a proposed schedule for filing the parties' respective Motion materials. (b) Whether any Motion for a Confidentiality Order is contemplated, and if so, a proposed schedule for filing the parties' respective Motion materials. (c) Whether any Motion pursuant to Section 6(5)(a) or (b) of the PM (NOC) Regulations is contemplated, and if so, the timeframe for bringing such Motion. (d) A proposed schedule for the further steps to be taken in this application, including whether the parties have agreed to a partial or full reversal of the order of filing evidence, and if not, whether any Motion to that effect is contemplated, together with, as the case may be, a proposed schedule for filing the parties' respective Motion materials on such a Motion. (e) Both counsel's joint availabilities to participate in a case management telephone conference to discuss the proposals, issues or matters listed above." placed on file on 07-FEB-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 28-JAN-2013 re: New NOC; requires schedule

Covering letter from the Respondent Patentee dated 19-DEC-2012 concerning Doc. No. 11 placed on file on 19-DEC-2012

Affidavit of service of Cindy Sue Potter sworn on 18-DEC-2012 on behalf of Respondent confirming service of Doc.11 upon all parties by hand (Janssen) and by fax (remaining parties) on 18-DEC-2012 filed on 19-DEC-2012

Notice of appearance on behalf of the respondent patentee, Milennium Pharmaceuticals, Inc. filed on 19-DEC-2012

Affidavit of service of Cindy Sue Potter sworn on 17-DEC-2012 on behalf of Applicant confirming service of Doc.1 upon the Respondent Patentee, Millenium Pharmaceuticals, Inc. by personal service on 14-DEC-2012 filed on 17-DEC-2012

Affidavit of service of Dave Newell sworn on 11-DEC-2012 on behalf of Applicant confirming service of Doc.1 upon the Respondent, Minister of Health by personal service on 07-DEC-2012 filed on 17-DEC-2012

Affidavit of service of Dave Newell sworn on 11-DEC-2012 on behalf of Applicant confirming service of doc.1 upon the Respondent, TEVA by personal service on 07-DEC-2012 filed on 17-DEC-2012

Letter from Applicant dated 17-DEC-2012 enclosing 3 affidavits of service for filing received on 17-DEC-2012

Covering letter from Respondent, Teva Canada Limited dated 17-DEC-2012 concerning Doc. Nos. 6 7 placed on file on 17-DEC-2012

Solicitor's certificate of service on behalf of Bryan Norrie confirming service of doc. 6 Notice of Appearance upon all parties by telecopier on 17-DEC-2012 filed on 17-DEC-2012

Notice of appearance on behalf of Respondent, Teva Canada filed on 17-DEC-2012

Affidavit of service of James Adeney sworn on 13-DEC-2012 on behalf of Respondent (minister) confirming service of doc 4 upon all parties by telecopier on 11-DEC-2012 filed on 11-DEC-2012

Notice of appearance on behalf of Respondent (minister) filed on 11-DEC-2012

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 3 placed on file on 12-DEC-2012

Order dated 12-DEC-2012 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 12-DEC-2012 copies sent to parties entered in J. & O. Book, volume 1177 page(s) 392 - 392 Interlocutory Decision

Service copy of Doc. No. 1 with proof of service upon Deputy Attorney General of Canada on 10-DEC-2012 filed on 10-DEC-2012

Covering letter from Applicant dated 07-DEC-2012 concerning Doc. No. 1 placed on file on 07-DEC-2012

Notice of application and 2 copies with regard to S.55.2(4) of the Patent Act and S.6 of Patented Medecines(NOC)Regulations returnable (but no hearing date indicated at this time) filed on 07-DEC-2012 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes